BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rafii A, Mirshahi P, Poupot M, Faussat AM, Simon A, Ducros E, Mery E, Couderc B, Lis R, Capdet J, Bergalet J, Querleu D, Dagonnet F, Fournié JJ, Marie JP, Pujade-Lauraine E, Favre G, Soria J, Mirshahi M. Oncologic trogocytosis of an original stromal cells induces chemoresistance of ovarian tumours. PLoS One 2008;3:e3894. [PMID: 19079610 DOI: 10.1371/journal.pone.0003894] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Ullah M, Azazzen D, Kaci R, Benabbou N, Pujade Lauraine E, Pocard M, Mirshahi M. High Expression of HLA-G in Ovarian Carcinomatosis: The Role of Interleukin-1β. Neoplasia 2019;21:331-42. [PMID: 30802770 DOI: 10.1016/j.neo.2019.01.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
2 Vaidya FU, Sufiyan Chhipa A, Mishra V, Gupta VK, Rawat SG, Kumar A, Pathak C. Molecular and cellular paradigms of multidrug resistance in cancer. Cancer Rep (Hoboken) 2020;:e1291. [PMID: 33052041 DOI: 10.1002/cnr2.1291] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
3 Gu Y, Lu H, Boisson-Vidal C, Li H, Bousquet G, Janin A, Di Benedetto M. [Resistance to anti-angiogenic therapy: a clinical and scientific current issue]. Med Sci (Paris) 2016;32:370-7. [PMID: 27137694 DOI: 10.1051/medsci/20163204015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
4 El-sehemy A, Postovit L, Fu Y. Nitric oxide signaling in human ovarian cancer: A potential therapeutic target. Nitric Oxide 2016;54:30-7. [DOI: 10.1016/j.niox.2016.02.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
5 Nakamura K, Nakayama M, Kawano M, Ishii T, Harigae H, Ogasawara K. NK-cell fratricide: Dynamic crosstalk between NK and cancer cells. Oncoimmunology 2013;2:e26529. [PMID: 24475374 DOI: 10.4161/onci.26529] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
6 Matte I, Lane D, Laplante C, Garde-Granger P, Rancourt C, Piché A. Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms. Int J Cancer 2015;137:289-98. [PMID: 25482018 DOI: 10.1002/ijc.29385] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
7 Pasquier J, Thawadi HA, Ghiabi P, Abu-Kaoud N, Maleki M, Guerrouahen BS, Vidal F, Courderc B, Ferron G, Martinez A. Microparticles mediated cross-talk between tumoral and endothelial cells promote the constitution of a pro-metastatic vascular niche through Arf6 up regulation. Cancer Microenviron. 2014;7:41-59. [PMID: 24424657 DOI: 10.1007/s12307-013-0142-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
8 Xie Y, Hicks MJ, Kaminsky SM, Moore MA, Crystal RG, Rafii A. AAV-mediated persistent bevacizumab therapy suppresses tumor growth of ovarian cancer. Gynecol Oncol 2014;135:325-32. [PMID: 25108232 DOI: 10.1016/j.ygyno.2014.07.105] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
9 Rechavi O, Kalman M, Fang Y, Vernitsky H, Jacob-Hirsch J, Foster LJ, Kloog Y, Goldstein I. Trans-SILAC: sorting out the non-cell-autonomous proteome. Nat Methods 2010;7:923-7. [PMID: 20935649 DOI: 10.1038/nmeth.1513] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
10 Pasquet M, Golzio M, Mery E, Rafii A, Benabbou N, Mirshahi P, Hennebelle I, Bourin P, Allal B, Teissie J, Mirshahi M, Couderc B. Hospicells (ascites-derived stromal cells) promote tumorigenicity and angiogenesis. Int J Cancer 2010;126:2090-101. [PMID: 19739074 DOI: 10.1002/ijc.24886] [Cited by in Crossref: 12] [Cited by in F6Publishing: 35] [Article Influence: 1.0] [Reference Citation Analysis]
11 Touboul C, Lis R, Al Farsi H, Raynaud CM, Warfa M, Althawadi H, Mery E, Mirshahi M, Rafii A. Mesenchymal stem cells enhance ovarian cancer cell infiltration through IL6 secretion in an amniochorionic membrane based 3D model. J Transl Med 2013;11:28. [PMID: 23369187 DOI: 10.1186/1479-5876-11-28] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 5.3] [Reference Citation Analysis]
12 Jo Y, Choi N, Kim K, Koo HJ, Choi J, Kim HN. Chemoresistance of Cancer Cells: Requirements of Tumor Microenvironment-mimicking In Vitro Models in Anti-Cancer Drug Development. Theranostics 2018;8:5259-75. [PMID: 30555545 DOI: 10.7150/thno.29098] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 13.3] [Reference Citation Analysis]
13 Clairambault J. Modelling Physiological and Pharmacological Control on Cell Proliferation to Optimise Cancer Treatments. Math Model Nat Phenom 2009;4:12-67. [DOI: 10.1051/mmnp/20094302] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
14 D'Asti E, Garnier D, Lee TH, Montermini L, Meehan B, Rak J. Oncogenic extracellular vesicles in brain tumor progression. Front Physiol 2012;3:294. [PMID: 22934045 DOI: 10.3389/fphys.2012.00294] [Cited by in Crossref: 45] [Cited by in F6Publishing: 58] [Article Influence: 4.5] [Reference Citation Analysis]
15 Velaei K, Samadi N, Barazvan B, Soleimani Rad J. Tumor microenvironment-mediated chemoresistance in breast cancer. Breast 2016;30:92-100. [PMID: 27668856 DOI: 10.1016/j.breast.2016.09.002] [Cited by in Crossref: 68] [Cited by in F6Publishing: 70] [Article Influence: 11.3] [Reference Citation Analysis]
16 Pascual-Antón L, Cardeñes B, Sainz de la Cuesta R, González-Cortijo L, López-Cabrera M, Cabañas C, Sandoval P. Mesothelial-to-Mesenchymal Transition and Exosomes in Peritoneal Metastasis of Ovarian Cancer. Int J Mol Sci 2021;22:11496. [PMID: 34768926 DOI: 10.3390/ijms222111496] [Reference Citation Analysis]
17 Weiss C, Uziel O, Wolach O, Nordenberg J, Beery E, Bulvick S, Kanfer G, Cohen O, Ram R, Bakhanashvili M, Magen-Nativ H, Shilo N, Lahav M. Differential downregulation of telomerase activity by bortezomib in multiple myeloma cells-multiple regulatory pathways in vitro and ex vivo. Br J Cancer 2012;107:1844-52. [PMID: 23169337 DOI: 10.1038/bjc.2012.460] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
18 Touboul C, Vidal F, Pasquier J, Lis R, Rafii A. Role of mesenchymal cells in the natural history of ovarian cancer: a review. J Transl Med 2014;12:271. [PMID: 25303976 DOI: 10.1186/s12967-014-0271-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
19 Lorz A, Lorenzi T, Hochberg ME, Clairambault J, Perthame B. Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies. ESAIM: M2AN 2013;47:377-99. [DOI: 10.1051/m2an/2012031] [Cited by in Crossref: 76] [Cited by in F6Publishing: 28] [Article Influence: 8.4] [Reference Citation Analysis]
20 Benabbou N, Mirshahi P, Cadillon M, Soria J, Therwath A, Mirshahi M. Hospicells promote upregulation of the ATP-binding cassette genes by insulin-like growth factor-I via the JAK2/STAT3 signaling pathway in an ovarian cancer cell line. Int J Oncol 2013;43:685-94. [PMID: 23857432 DOI: 10.3892/ijo.2013.2017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
21 Dittmer J, Leyh B. The impact of tumor stroma on drug response in breast cancer. Semin Cancer Biol. 2015;31:3-15. [PMID: 24912116 DOI: 10.1016/j.semcancer.2014.05.006] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 7.4] [Reference Citation Analysis]
22 Miyake K, Karasuyama H. The Role of Trogocytosis in the Modulation of Immune Cell Functions. Cells 2021;10:1255. [PMID: 34069602 DOI: 10.3390/cells10051255] [Reference Citation Analysis]
23 Martinet L, Poupot R, Mirshahi P, Rafii A, Fournié JJ, Mirshahi M, Poupot M. Hospicells derived from ovarian cancer stroma inhibit T-cell immune responses. Int J Cancer 2010;126:2143-52. [PMID: 19739080 DOI: 10.1002/ijc.24881] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
24 Pasquier J, Magal P, Boulangé-Lecomte C, Webb G, Le Foll F. Consequences of cell-to-cell P-glycoprotein transfer on acquired multidrug resistance in breast cancer: a cell population dynamics model. Biol Direct 2011;6:5. [PMID: 21269489 DOI: 10.1186/1745-6150-6-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
25 Castells M, Thibault B, Delord JP, Couderc B. Implication of tumor microenvironment in chemoresistance: tumor-associated stromal cells protect tumor cells from cell death. Int J Mol Sci 2012;13:9545-71. [PMID: 22949815 DOI: 10.3390/ijms13089545] [Cited by in Crossref: 155] [Cited by in F6Publishing: 149] [Article Influence: 15.5] [Reference Citation Analysis]
26 Saunders JH, Onion D, Collier P, Dorrington MS, Argent RH, Clarke PA, Reece-Smith AM, Parsons SL, Grabowska AM. Individual patient oesophageal cancer 3D models for tailored treatment. Oncotarget 2017;8:24224-36. [PMID: 27736801 DOI: 10.18632/oncotarget.12500] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
27 Sousa D, Lima RT, Vasconcelos MH. Intercellular Transfer of Cancer Drug Resistance Traits by Extracellular Vesicles. Trends Mol Med 2015;21:595-608. [PMID: 26432017 DOI: 10.1016/j.molmed.2015.08.002] [Cited by in Crossref: 81] [Cited by in F6Publishing: 81] [Article Influence: 13.5] [Reference Citation Analysis]
28 Mikuła-Pietrasik J, Uruski P, Tykarski A, Książek K. The peritoneal "soil" for a cancerous "seed": a comprehensive review of the pathogenesis of intraperitoneal cancer metastases. Cell Mol Life Sci 2018;75:509-25. [PMID: 28956065 DOI: 10.1007/s00018-017-2663-1] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 13.0] [Reference Citation Analysis]
29 Pasquier J, Guerrouahen BS, Al Thawadi H, Ghiabi P, Maleki M, Abu-Kaoud N, Jacob A, Mirshahi M, Galas L, Rafii S, Le Foll F, Rafii A. Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance. J Transl Med 2013;11:94. [PMID: 23574623 DOI: 10.1186/1479-5876-11-94] [Cited by in Crossref: 243] [Cited by in F6Publishing: 231] [Article Influence: 27.0] [Reference Citation Analysis]
30 Pasquier J, Galas L, Boulangé-Lecomte C, Rioult D, Bultelle F, Magal P, Webb G, Le Foll F. Different modalities of intercellular membrane exchanges mediate cell-to-cell p-glycoprotein transfers in MCF-7 breast cancer cells. J Biol Chem 2012;287:7374-87. [PMID: 22228759 DOI: 10.1074/jbc.M111.312157] [Cited by in Crossref: 88] [Cited by in F6Publishing: 51] [Article Influence: 8.8] [Reference Citation Analysis]
31 Kongsomros S, Manopwisedjaroen S, Chaopreecha J, Wang SF, Borwornpinyo S, Thitithanyanont A. Rapid and Efficient Cell-to-Cell Transmission of Avian Influenza H5N1 Virus in MDCK Cells Is Achieved by Trogocytosis. Pathogens 2021;10:483. [PMID: 33923524 DOI: 10.3390/pathogens10040483] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
32 Castells M, Milhas D, Gandy C, Thibault B, Rafii A, Delord JP, Couderc B. Microenvironment mesenchymal cells protect ovarian cancer cell lines from apoptosis by inhibiting XIAP inactivation. Cell Death Dis 2013;4:e887. [PMID: 24176845 DOI: 10.1038/cddis.2013.384] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
33 Thibault B, Castells M, Delord JP, Couderc B. Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition. Cancer Metastasis Rev 2014;33:17-39. [PMID: 24357056 DOI: 10.1007/s10555-013-9456-2] [Cited by in Crossref: 104] [Cited by in F6Publishing: 99] [Article Influence: 14.9] [Reference Citation Analysis]
34 Gary R, Voelkl S, Palmisano R, Ullrich E, Bosch JJ, Mackensen A. Antigen-Specific Transfer of Functional Programmed Death Ligand 1 from Human APCs onto CD8 + T Cells via Trogocytosis. J I 2012;188:744-52. [DOI: 10.4049/jimmunol.1101412] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
35 Jouvin I, Najah H, Pimpie C, Canet Jourdan C, Kaci R, Mirshahi M, Eveno C, Pocard M. Reduction of carcinomatosis risk using icodextrin as a carrier solution of intraperitoneal oxaliplatin chemotherapy. Eur J Surg Oncol 2017;43:1088-94. [PMID: 28089175 DOI: 10.1016/j.ejso.2016.12.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
36 Vera N, Acuña-Gallardo S, Grünenwald F, Caceres-Verschae A, Realini O, Acuña R, Lladser A, Illanes SE, Varas-Godoy M. Small Extracellular Vesicles Released from Ovarian Cancer Spheroids in Response to Cisplatin Promote the Pro-Tumorigenic Activity of Mesenchymal Stem Cells. Int J Mol Sci 2019;20:E4972. [PMID: 31600881 DOI: 10.3390/ijms20204972] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
37 Lis R, Touboul C, Mirshahi P, Ali F, Mathew S, Nolan DJ, Maleki M, Abdalla SA, Raynaud CM, Querleu D. Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12. Int J Cancer. 2011;128:715-725. [PMID: 20725999 DOI: 10.1002/ijc.25619] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 6.4] [Reference Citation Analysis]
38 Rossi EA, Goldenberg DM, Michel R, Rossi DL, Wallace DJ, Chang CH. Trogocytosis of multiple B-cell surface markers by CD22 targeting with epratuzumab. Blood 2013;122:3020-9. [PMID: 23821660 DOI: 10.1182/blood-2012-12-473744] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 8.2] [Reference Citation Analysis]
39 Luo X, Huang S, He N, Liu C, Chen Y, Liu Y, Mi X, Li N, Sun P, Li Z, Xiang R, Su W. Inflammatory Human Umbilical Cord-Derived Mesenchymal Stem Cells Promote Stem Cell-Like Characteristics of Cancer Cells in an IL-1β-Dependent Manner. Biomed Res Int 2018;2018:7096707. [PMID: 29670904 DOI: 10.1155/2018/7096707] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
40 Melzer C, Yang Y, Hass R. Interaction of MSC with tumor cells. Cell Commun Signal 2016;14:20. [PMID: 27608835 DOI: 10.1186/s12964-016-0143-0] [Cited by in Crossref: 94] [Cited by in F6Publishing: 98] [Article Influence: 15.7] [Reference Citation Analysis]
41 Pasquier J, Abu-Kaoud N, Abdesselem H, Madani A, Hoarau-Véchot J, Thawadi HA, Vidal F, Couderc B, Favre G, Rafii A. SDF-1alpha concentration dependent modulation of RhoA and Rac1 modifies breast cancer and stromal cells interaction. BMC Cancer 2015;15:569. [PMID: 26231656 DOI: 10.1186/s12885-015-1556-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
42 Ducros E, Mirshahi S, Azzazene D, Camilleri-Broët S, Mery E, Al Farsi H, Althawadi H, Besbess S, Chidiac J, Pujade-Lauraine E, Therwath A, Soria J, Mirshahi M. Endothelial protein C receptor expressed by ovarian cancer cells as a possible biomarker of cancer onset. Int J Oncol 2012;41:433-40. [PMID: 22614534 DOI: 10.3892/ijo.2012.1492] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
43 Le Naour A, Prat M, Thibault B, Mével R, Lemaitre L, Leray H, Joubert MV, Coulson K, Golzio M, Lefevre L, Mery E, Martinez A, Ferron G, Delord JP, Coste A, Couderc B. Tumor cells educate mesenchymal stromal cells to release chemoprotective and immunomodulatory factors. J Mol Cell Biol 2020;12:202-15. [PMID: 31504643 DOI: 10.1093/jmcb/mjz090] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
44 Melzer C, von der Ohe J, Lehnert H, Ungefroren H, Hass R. Cancer stem cell niche models and contribution by mesenchymal stroma/stem cells. Mol Cancer 2017;16:28. [PMID: 28148265 DOI: 10.1186/s12943-017-0595-x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 14.6] [Reference Citation Analysis]
45 Mink SR, Vashistha S, Zhang W, Hodge A, Agus DB, Jain A. Cancer-associated fibroblasts derived from EGFR-TKI-resistant tumors reverse EGFR pathway inhibition by EGFR-TKIs. Mol Cancer Res. 2010;8:809-820. [PMID: 20530582 DOI: 10.1158/1541-7786.mcr-09-0460] [Cited by in Crossref: 50] [Cited by in F6Publishing: 33] [Article Influence: 4.2] [Reference Citation Analysis]
46 Nikoo S, Ebtekar M, Jeddi-Tehrani M, Shervin A, Bozorgmehr M, Vafaei S, Kazemnejad S, Zarnani AH. Menstrual blood-derived stromal stem cells from women with and without endometriosis reveal different phenotypic and functional characteristics. Mol Hum Reprod 2014;20:905-18. [PMID: 24939730 DOI: 10.1093/molehr/gau044] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
47 Prieto-Vila M, Takahashi RU, Usuba W, Kohama I, Ochiya T. Drug Resistance Driven by Cancer Stem Cells and Their Niche. Int J Mol Sci. 2017;18. [PMID: 29194401 DOI: 10.3390/ijms18122574] [Cited by in Crossref: 207] [Cited by in F6Publishing: 198] [Article Influence: 41.4] [Reference Citation Analysis]
48 Ahmed KA, Xiang J. Mechanisms of cellular communication through intercellular protein transfer. J Cell Mol Med 2011;15:1458-73. [PMID: 20070437 DOI: 10.1111/j.1582-4934.2010.01008.x] [Cited by in Crossref: 83] [Cited by in F6Publishing: 80] [Article Influence: 6.9] [Reference Citation Analysis]
49 Pasquier J, Gosset M, Geyl C, Hoarau-Véchot J, Chevrot A, Pocard M, Mirshahi M, Lis R, Rafii A, Touboul C. CCL2/CCL5 secreted by the stroma induce IL-6/PYK2 dependent chemoresistance in ovarian cancer. Mol Cancer 2018;17:47. [PMID: 29455640 DOI: 10.1186/s12943-018-0787-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 7.5] [Reference Citation Analysis]
50 Pasquier J, Vidal F, Hoarau-Véchot J, Bonneau C, Daraï E, Touboul C, Rafii A. Surgical peritoneal stress creates a pro-metastatic niche promoting resistance to apoptosis via IL-8. J Transl Med 2018;16:271. [PMID: 30285881 DOI: 10.1186/s12967-018-1643-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
51 Pasquier J, Rafii A. Role of the microenvironment in ovarian cancer stem cell maintenance. Biomed Res Int 2013;2013:630782. [PMID: 23484135 DOI: 10.1155/2013/630782] [Cited by in Crossref: 12] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
52 HoWangYin KY, Alegre E, Daouya M, Favier B, Carosella ED, LeMaoult J. Different functional outcomes of intercellular membrane transfers to monocytes and T cells. Cell Mol Life Sci 2010;67:1133-45. [PMID: 20238479 DOI: 10.1007/s00018-009-0239-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
53 Suh DH, Kim HS, Kim B, Song YS. Metabolic orchestration between cancer cells and tumor microenvironment as a co-evolutionary source of chemoresistance in ovarian cancer: a therapeutic implication. Biochem Pharmacol. 2014;92:43-54. [PMID: 25168677 DOI: 10.1016/j.bcp.2014.08.011] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
54 Kitayama J, Emoto S, Yamaguchi H, Ishigami H, Watanabe T. CD90+ mesothelial-like cells in peritoneal fluid promote peritoneal metastasis by forming a tumor permissive microenvironment. PLoS One 2014;9:e86516. [PMID: 24466130 DOI: 10.1371/journal.pone.0086516] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
55 Zhou HL, Zheng YJ, Cheng XZ, Lv YS, Gao R, Mao HP, Chen Q. Intercellular transfer of P-glycoprotein from the drug resistant human bladder cancer cell line BIU-87 does not require cell-to-cell contact. J Urol 2013;190:1069-75. [PMID: 23618585 DOI: 10.1016/j.juro.2013.04.053] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
56 Mehraj U, Dar AH, Wani NA, Mir MA. Tumor microenvironment promotes breast cancer chemoresistance. Cancer Chemother Pharmacol 2021;87:147-58. [PMID: 33420940 DOI: 10.1007/s00280-020-04222-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
57 Castells M, Thibault B, Mery E, Golzio M, Pasquet M, Hennebelle I, Bourin P, Mirshahi M, Delord JP, Querleu D, Couderc B. Ovarian ascites-derived Hospicells promote angiogenesis via activation of macrophages. Cancer Lett 2012;326:59-68. [PMID: 22824244 DOI: 10.1016/j.canlet.2012.07.020] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
58 Tang XH, Li M, Deng S, Lu MS. Cross-reacting material 197, a heparin-binding EGF-like growth factor inhibitor, reverses the chemoresistance in human cisplatin-resistant ovarian cancer. Anticancer Drugs. 2014;25:1201-1210. [PMID: 25115341 DOI: 10.1097/cad.0000000000000155] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
59 Varas-Godoy M, Rice G, Illanes SE. The Crosstalk between Ovarian Cancer Stem Cell Niche and the Tumor Microenvironment. Stem Cells Int 2017;2017:5263974. [PMID: 28819364 DOI: 10.1155/2017/5263974] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
60 Laplagne C, Domagala M, Le Naour A, Quemerais C, Hamel D, Fournié JJ, Couderc B, Bousquet C, Ferrand A, Poupot M. Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression. Int J Mol Sci 2019;20:E4719. [PMID: 31547627 DOI: 10.3390/ijms20194719] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]
61 Levi M, Brunetti B, Sarli G, Benazzi C. Immunohistochemical Expression of P-glycoprotein and Breast Cancer Resistance Protein in Canine Mammary Hyperplasia, Neoplasia and Supporting Stroma. J Comp Pathol 2016;155:277-85. [PMID: 27528038 DOI: 10.1016/j.jcpa.2016.07.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
62 Canonico B, Luchetti F, Arcangeletti M, Guescini M, Degli Esposti M, Papa S. Flow cytometric analyses disclose intercellular communications in FasL-stimulated T cells: results and trouble shooting. Cytometry A 2012;81:5-8. [PMID: 21990135 DOI: 10.1002/cyto.a.21151] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
63 Kitayama J, Emoto S, Yamaguchi H, Ishigami H, Yamashita H, Seto Y, Matsuzaki K, Watanabe T. CD90(+)CD45(-) intraperitoneal mesothelial-like cells inhibit T cell activation by production of arginase I. Cell Immunol 2014;288:8-14. [PMID: 24556645 DOI: 10.1016/j.cellimm.2014.01.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
64 Kloc M, Kubiak JZ, Li XC, Ghobrial RM. Noncanonical intercellular communication in immune response. World J Immunol 2016; 6(1): 67-74 [DOI: 10.5411/wji.v6.i1.67] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
65 Rak J, Guha A. Extracellular vesicles - vehicles that spread cancer genes. Bioessays 2012;34:489-97. [DOI: 10.1002/bies.201100169] [Cited by in Crossref: 114] [Cited by in F6Publishing: 111] [Article Influence: 11.4] [Reference Citation Analysis]
66 Li KJ, Wu CH, Lu CH, Shen CY, Kuo YM, Tsai CY, Hsieh SC, Yu CL. Trogocytosis between Non-Immune Cells for Cell Clearance, and among Immune-Related Cells for Modulating Immune Responses and Autoimmunity. Int J Mol Sci 2021;22:2236. [PMID: 33668117 DOI: 10.3390/ijms22052236] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
67 Benabbou N, Mirshahi P, Bordu C, Faussat AM, Tang R, Therwath A, Soria J, Marie JP, Mirshahi M. A subset of bone marrow stromal cells regulate ATP-binding cassette gene expression via insulin-like growth factor-I in a leukemia cell line. Int J Oncol 2014;45:1372-80. [PMID: 25095896 DOI: 10.3892/ijo.2014.2569] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]